DOI=10.4172/2161-0681.1000119
Fredika M. Robertson, Khoi Chu, Sandra V. Fernandez, Zhao-Mei Mu, Xue-Jun Zhang, Hui Liu, Kimberly M. Boley, R. Katherine Alpaugh, Zai-Ming Ye, Moishia C. Wright, Annie Z. Luo ...Show all 17 authors... , Ricardo Oraes, Hong Wu, Matthew Brent Zook, Sanford H. Barsky, Savitri Krishnamurthy, Massimo Cristofanilli; Show fewer authors
Genomic profiling of pre-clinical models of inflammatory breast cancer identifies a signature of epithelial plasticity and suppression of TGFbeta signaling.
J. Clin. Exp. Pathol. 2:119.1-119.11(2012)

PubMed=23784380; DOI=10.1007/s10549-013-2600-4; PMCID=PMC4273486
Sandra V. Fernandez, Fredika M. Robertson, Jian-Ming Pei, Lucy Doris Aburto-Chumpitaz, Zhao-Mei Mu, Khoi Chu, R. Katherine Alpaugh, Yong Huang, Yu Cao, Zai-Ming Ye, Kathy Q. Cai ...Show all 16 authors... , Kimberly M. Boley, Andres J.P. Klein-Szanto, Karthik Devarajan, Sankar Addya, Massimo Cristofanilli; Show fewer authors
Inflammatory breast cancer (IBC): clues for targeted therapies.
Breast Cancer Res. Treat. 140:23-33(2013)

PubMed=35042871; DOI=10.1038/s41523-021-00379-6; PMCID=PMC8766434
Charlotte Rypens, Francois Bertucci, Pascal Finetti, Fredika M. Robertson, Sandra V. Fernandez, Naoto Tada Ueno, Wendy A. Woodward, Kenneth Van Golen, Peter Vermeulen, Luc Dirix, Patrice Viens ...Show all 15 authors... , Daniel Birnbaum, Gayathri R. Devi, Massimo Cristofanilli, Steven Van Laere; Show fewer authors
Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC.
NPJ Breast Cancer 8:12.1-12.12(2022)